Regression Analysis of Combined Gene Expression Regulation in Acute Myeloid Leukemia

PLoS Computational Biology

Volumn 10, Issue 10, 2014, Pages

  Li, Yue ^a,b   Liang, Minggao ^a   Zhang, Zhaolei ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; CELL CULTURE; DISEASES; ENCODING (SYMBOLS); GENE EXPRESSION REGULATION; RNA; TRANSCRIPTION;

ACUTE MYELOID LEUKEMIA; CANCER GENOME; COMBINATORIAL FUNCTIONS; COPY NUMBER VARIATIONS; DNA METHYLATION; EPIGENETICS; EXPRESSION REGULATION; GENES EXPRESSION; LARGE AMOUNTS OF DATA; POST-TRANSCRIPTIONAL REGULATIONS;

REGRESSION ANALYSIS;

MESSENGER RNA; MICRORNA; MICRORNA 548P; PROTEIN C FOS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CALCULATION; CANCER PROGNOSIS; CANCER SURVIVAL; GENE INTERACTION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PHENOTYPE; PROTEIN BINDING; REGRESSION ANALYSIS OF COMBINED GENE EXPRESSION REGULATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; PROCEDURES; REGRESSION ANALYSIS;

ADULT; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; REGRESSION ANALYSIS;

EID: 84908328316     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003908     Document Type: Article

References (75)

1. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, et al. (2013) Landscape of transcription in human cells. Nature 488: 101–108.
2. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM, (2009) A census of human transcription factors: function, expression and evolution. Nature reviews Genetics 10: 252–263.
3. Bartel DP, (2009) MicroRNAs: Target Recognition and Regulatory Functions. Cell 136: 215–233.
4. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835–840.
5. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proceedings of the National Academy of Sciences of the United States of America 98: 15149–15154.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838.
7. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, et al. (2013) Architecture of the human regulatory network derived from ENCODE data. Nature 488: 91–100.
8. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061–1068.
9. The Cancer Genome Atlas Research Network (2013) Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. New England Journal of Medicine 368: 2059–2074.
10. Cheng C, Yan KK, Hwang W, Qian J, Bhardwaj N, et al. (2011) Construction and analysis of an integrated regulatory network derived from high-throughput sequencing data. PLoS Computational Biology 7: e1002190.
11. Cheng C, Alexander R, Min R, Leng J, Yip KY, et al. (2012) Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Research 22: 1658–1667.
12. Setty M, Helmy K, Khan AA, Silber J, Arvey A, et al. (2012) Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Molecular systems biology 8: 1–16.
13. Jacobsen A, Silber J, Harinath G, Huse JT, Schultz N, et al. (2013) Analysis of microRNA-target interactions across diverse cancer types. Nature structural & molecular biology 20: 1325–1332.
14. ENCODE Project Consortium (2011) A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biology 9: e1001046.
15. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, Delwel R, Valk PJM, et al. (2003) The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 101: 1111–1117.
16. Milde-Langosch K, (2005) The Fos family of transcription factors and their role in tumourigenesis. European journal of cancer (Oxford, England: 1990) 41: 2449–2461.
17. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N, (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proceedings of the National Academy of Sciences of the United States of America 103: 2746–2751.
18. Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, et al. (2003) Network component analysis: reconstruction of regulatory signals in biological systems. Proceedings of the National Academy of Sciences 100: 15522–15527.
19. Gao F, Foat BC, Bussemaker HJ, (2004) Defining transcriptional networks through integrative modeling of mrna expression and transcription factor binding data. BMC bioinformatics 5: 31.
20. Bussemaker HJ, Foat BC, Ward LD, (2007) Predictive modeling of genome-wide mrna expression: from modules to molecules. Annual review of biophysics and biomolecular structure 36: 329.
21. Friedman RC, Farh KKH, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 19: 92–105.
22. Tibshirani R, (1996) Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B (Methodological) 267–288.
23. Wingender E, Chen X, Hehl R, Karas H, Liebich I, et al. (2000) TRANSFAC: an integrated system for gene expression regulation. Nucleic acids research 28: 316–319.
24. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nature Methods 4: 1045–1049.
25. Lu Y, Zhou Y, Qu W, Deng M, Zhang C, (2011) A Lasso regression model for the construction of microRNA-target regulatory networks. Bioinformatics (Oxford, England) 27: 2406–2413.
26. Chen X, Slack FJ, Zhao H, (2013) Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions. Bioinformatics (Oxford, England) 29: 2137–2145.
27. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic acids research 39: D163–9.
28. Lal A, Thomas MP, Altschuler G, Navarro F, O′Day E, et al. (2011) Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling. PLoS Genetics 7: e1002363.
29. Lan X, Witt H, Katsumura K, Ye Z, Wang Q, et al. (2012) Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages. Nucleic Acids Research 40: 7690–7704.
30. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289–300.
31. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics 25: 25–29.
32. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545–15550.
33. Arteaga MF, Mikesch JH, Qiu J, Christensen J, Helin K, et al. (2013) The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer cell 23: 376–389.
34. Huang MJ, Cheng Yc, Liu CR, Lin S, Liu HE, (2006) A small-molecule c-myc inhibitor, 10058-f4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Experimental hematology 34: 1480–1489.
35. Dang CV, (1999) c-myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and cellular biology 19: 1–11.
36. Zada A, Pulikkan J, Bararia D, Geletu M, Trivedi A, et al. (2006) Proteomic discovery of max as a novel interacting partner of c/ebpα: a myc/max/mad link. Leukemia 20: 2137–2146.
37. Bossone SA, Asselin C, Patel AJ, Marcu KB, (1992) Maz, a zinc finger protein, binds to c-myc and c2 gene sequences regulating transcriptional initiation and termination. Proceedings of the National Academy of Sciences 89: 7452–7456.
38. Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, et al. (2000) Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Experimental hematology 28: 1413–1422.
39. Lunardi A, Guarnerio J, Wang G, Maeda T, Pandolfi PP, (2013) Role of lrf/pokemon in lineage fate decisions. Blood 121: 2845–2853.
40. Friedman AD, (2007) C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development. Blood cells, molecules & diseases 39: 340–343.
41. Wang XS, Gong JN, Yu J, Wang F, Zhang XH, et al. (2012) Microrna-29a and microrna-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119: 4992–5004.
42. Skene PJ, Hernandez AE, Groudine M, Henikoff S (2014) The nucleosomal barrier to promoter escape by rna polymerase ii is overcome by the chromatin remodeler chd1. eLife 3.
43. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, et al. (2006) The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing hox gene expression. Proceedings of the National Academy of Sciences of the United States of America 103: 1018–1023.
44. Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, et al. (2007) Haploinsufficiency of egr1, a candidate gene in the del (5q), leads to the development of myeloid disorders. Blood 110: 719–726.
45. Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, et al. (2014) Association of the type of 5q loss with complex karyotype, clonal evolution, tp53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome. Genes, Chromosomes and Cancer 53: 402–410.
46. Cai DH, Wang D, Keefer JR, Hensley K, Friedman AD, (2006) Heterodimers Formed Via Leucine Zipper Interaction between C/EBP alpha and c-Jun or c-Fos Induce Monocytic Lineage Commitment. ASH Annual Meeting Abstracts 108: 1170.
47. Duprez E, Wagner K, Koch H, Tenen DG, (2003) C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. The EMBO journal 22: 5806–5816.
48. Crans HN, Sakamoto KM, (2001) Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia 15: 313–331.
49. Yao YL, Yang WM, Seto E, (2001) Regulation of transcription factor YY1 by acetylation and deacetylation. Molecular and cellular biology 21: 5979–5991.
50. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, et al. (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Research 20: 589–599.
51. Schotte D, Pieters R, Den Boer ML, (2012) MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 26: 1–12.
52. Morin RD, O′Connor MD, Griffith M, Kuchenbauer F, Delaney A, et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome research 18: 610–621.
53. Kjeldsen E, Roug AS, (2012) A novel unbalanced de novo translocation der (5) t (4; 5)(q26; q21. 1) in adult t-cell precursor lymphoblastic leukemia. Mol Cytogenet 5: 21.
54. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 13: 2498–2504.
55. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research 39: D945–50.
56. Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, et al. (2009) The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell cycle (Georgetown, Tex) 8: 1367–1372.
57. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nature Genetics 37: 495–500.
58. Balwierz PJ, Pachkov M, Arnold P, Gruber AJ, Zavolan M, et al. (2014) ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome Research 24: 869–884.
59. Healy S, Khan P, Davie JR, (2013) Immediate early response genes and cell transformation. Pharmacology & therapeutics 137: 64–77.
60. Staber PB, Linkesch W, Zauner D, Beham-Schmid C, Guelly C, et al. (2004) Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene 23: 894–904.
61. Serrano E, Lasa A, Perea G, Carnicer MJ, Brunet S, et al. (2006) Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta haematologica 116: 77–89.
62. Umeda S, Yamamoto K, Murayama T, Hidaka M, Kurata M, et al. (2012) Prognostic significance of hoxb4 in de novo acute myeloid leukemia. Hematology 17: 125–131.
63. Silva G, Cardoso BA, Belo H, Almeida AM, (2013) Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms. PloS one 8: e53766.
64. Zhou L, Zhang JS, Yu JC, Cui QC, Zhou WX, et al. (2010) Negative association of c-fos expression as a favorable prognostic indicator in gastric cancer. Archives of medical research 41: 201–206.
65. Oliveira-Ferrer L, Rößler K, Haustein V, Schröder C, Wicklein D, et al. (2014) c-FOS suppresses ovarian cancer progression by changing adhesion. British journal of cancer 110: 753–763.
66. Mahner S, Baasch C, Schwarz J, Hein S, Wölber L, et al. (2008) C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. British journal of cancer 99: 1269–1275.
67. Jin SP, Kim JH, Kim MA, Yang HK, Lee HE, et al. (2007) Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathology oncology research: POR 13: 284–289.
68. Zarubin T, Han J, (2005) Activation and signaling of the p38 MAP kinase pathway. Cell research 15: 11–18.
69. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, et al. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Molecular cell 1: 543–551.
70. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, et al. (2012) The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Research 22: 1775–1789.
71. Li Y, Liang C, Wong KC, Jin K, Zhang Z, (2014) Inferring probabilistic mirna–mrna interaction signatures in cancers: a role-switch approach. Nucleic Acids Research 42: e76.
72. Friedman J, Hastie T, Tibshirani R, (2010) Regularization Paths for Generalized Linear Models via Coordinate Descent. Journal of Statistical Software 33: 1–22.
73. Sing T, Sander O, Beerenwinkel N, Lengauer T, (2005) Rocr: visualizing classifier performance in r. Bioinformatics 21: 7881.
74. Durinck S, Spellman PT, Birney E, Huber W, (2009) Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nature protocols 4: 1184–1191.
75. Li Y, Liang C, Wong KC, Luo J, Zhang Z, (2014) Mirsynergy: detecting synergistic mirna regulatory modules by overlapping neighbourhood expansion. Bioinformatics 30: 2627–2635.